Bristol Myers Squibb Foundation Inc

Bristol Myers Squibb Foundation experiences significant financial deficits in recent years, with liabilities exceeding assets in 2023.

EIN: 133127947 · Princeton, NJ · Updated: 2026-03-28

$83.0MRevenue
$83.3MAssets
75/100Mission Score (Good)
Bristol Myers Squibb Foundation Inc Financial Summary
MetricValue
Total Revenue$83.0M
Total Expenses$87.1M
Program Spending90%
CEO/Top Officer Pay$185
Net Assets$-40,320,456
Transparency Score75/100

Is Bristol Myers Squibb Foundation Inc Legit?

Some Concerns

GoodFiling Consistency
ExcellentSpending Efficiency
GoodTransparency
3 FoundRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

Bristol Myers Squibb Foundation Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About Bristol Myers Squibb Foundation Inc

Bristol Myers Squibb Foundation Inc (EIN: 133127947) is a nonprofit organization based in Princeton, NJ. The organization reported total revenue of $83.0M and total assets of $83.3M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Bristol Myers Squibb Foundation Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

44Years Operating
MajorSize Classification
10Years of Filings
MixedRevenue Trajectory

Bristol Myers Squibb Foundation Inc is a major nonprofit that has been operating for 44 years, with 10 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of -14.3%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Total Revenue$5.6M
Total Expenses$87.1M
Surplus / Deficit$-81,489,186
Total Assets$68.8M
Total Liabilities$109.1M
Net Assets$-40,320,456
Operating Margin-1452.5%
Debt-to-Asset Ratio158.6%
Months of Reserves9.5 months

Financial Health Grade: C

In 2023, Bristol Myers Squibb Foundation Inc reported a deficit of $81.5M with expenses exceeding revenue, holds 9.5 months of operating reserves (strong position), has a debt-to-asset ratio of 158.6% (high leverage).

Financial Trends

Over 10 years of filings (2011–2023), Bristol Myers Squibb Foundation Inc's revenue has declined at a compound annual growth rate (CAGR) of -14.3%.

YearRevenue ChangeExpense ChangeAsset Change
2023-76.0%+91.0%-40.7%
2022+49881.2%-16.1%-20.9%
2021-100.0%-53.7%-21.0%
2020+103.1%+207.1%+58.9%
2019+47.6%+29.2%+21.0%

IRS Tax-Exempt Classification

IRS Classification Codes1000
IRS Ruling Date1982

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

The Bristol Myers Squibb Foundation Inc. exhibits a highly variable financial performance over the past decade, with significant fluctuations in both revenue and expenses. For instance, in 2023, the organization reported revenue of $5,610,141 against expenses of $87,099,327, indicating a substantial deficit. This trend of expenses significantly exceeding revenue is also observed in 2022 ($23M revenue vs. $45M expenses) and 2021 ($46K revenue vs. $54M expenses). While the foundation has substantial assets, reaching $185M in 2020, its liabilities have also shown considerable growth, peaking at $109M in 2023, which is a concern for long-term financial stability. The consistent reporting of 0% officer compensation across all filings suggests a strong commitment to directing funds towards its mission rather than executive salaries, which is a positive indicator of financial transparency and efficiency. The foundation's financial health appears to be heavily reliant on large, infrequent revenue injections, as seen in 2020 with over $120M in revenue, which allowed it to cover significant expenses. However, periods of low revenue coupled with high expenses, such as in 2023, lead to substantial net asset decreases. The high liabilities in recent years, particularly in 2023, warrant closer examination to understand their nature and potential impact on future operations. Despite these fluctuations, the absence of officer compensation is a notable strength, indicating that the organization's resources are not being diverted to high executive salaries.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Bristol Myers Squibb Foundation Inc with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

According to IRS 990 filings, Bristol Myers Squibb Foundation Inc allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

$5.6MTotal Revenue
$87.1MTotal Expenses
$68.8MTotal Assets
$109.1MTotal Liabilities
$-40,320,456Net Assets

Executive Compensation Analysis

Executive compensation is consistently reported as 0% across all available filings, indicating that no portion of the organization's funds are allocated to officer salaries, which is highly commendable for an organization of its size with assets reaching over $185 million in some years.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Bristol Myers Squibb Foundation Inc's IRS 990 filings:

Strengths

The following positive indicators were identified for Bristol Myers Squibb Foundation Inc:

Frequently Asked Questions about Bristol Myers Squibb Foundation Inc

Is Bristol Myers Squibb Foundation Inc a legitimate charity?

Based on AI analysis of IRS 990 filings, Bristol Myers Squibb Foundation Inc (EIN: 133127947) some concerns. Mission Score: 75/100. 3 red flags identified, 3 strengths noted.

How does Bristol Myers Squibb Foundation Inc spend its money?

Bristol Myers Squibb Foundation Inc directs 90% of its spending to programs and services. The remaining budget covers administration and fundraising costs.

Are donations to Bristol Myers Squibb Foundation Inc tax-deductible?

Bristol Myers Squibb Foundation Inc is registered as a tax-exempt nonprofit (EIN: 133127947). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

How much does the Bristol Myers Squibb Foundation Inc CEO make?

Bristol Myers Squibb Foundation Inc's highest-compensated officer earns $185 annually. The organization reported $83.0M in total revenue. Executive compensation data is disclosed in IRS 990 filings.

What percentage of Bristol Myers Squibb Foundation Inc's spending goes to programs?

Bristol Myers Squibb Foundation Inc directs 90% to programs, 3% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.

Where is Bristol Myers Squibb Foundation Inc located?

Bristol Myers Squibb Foundation Inc is headquartered in Princeton, New Jersey and files with the IRS under EIN 133127947.

How many years of IRS 990 filings does Bristol Myers Squibb Foundation Inc have?

Bristol Myers Squibb Foundation Inc has 10 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $83.0M in total revenue.

Is Bristol Myers Squibb Foundation Inc. financially stable given its recent deficits?

The foundation has experienced significant deficits in recent years, with expenses far exceeding revenue in 2023 ($87M expenses vs. $5.6M revenue), 2022 ($45M expenses vs. $23M revenue), and 2021 ($54M expenses vs. $46K revenue). Additionally, liabilities exceeded assets in 2023 ($109M liabilities vs. $68M assets), raising concerns about its short-term financial stability despite a history of substantial asset holdings.

What is the reason for the large fluctuations in revenue and expenses?

The IRS 990 data alone does not specify the exact reasons for these fluctuations. However, such patterns often indicate reliance on large, infrequent grants or contributions, or significant project-based spending that varies year-to-year. For example, the $120M revenue in 2020 likely funded the $117M expenses in the same year, suggesting a project-driven financial model.

How does the 0% officer compensation impact the organization's efficiency?

The consistent 0% officer compensation is a strong positive indicator of efficiency, as it means all funds are directed towards program delivery, administration, and fundraising, rather than executive salaries. This suggests a high dedication to the mission and efficient use of donor funds.

What is the nature of the high liabilities reported in recent years?

The IRS 990 summary data does not detail the nature of the liabilities. However, the significant increase to $109M in 2023 from $1.9M in 2019 warrants further investigation. These could include program-related payables, deferred revenue, or other financial obligations that impact the organization's net assets.

Filing History

IRS 990 filing history for Bristol Myers Squibb Foundation Inc showing financial trends over 10 years of public records:

Over 10 years of IRS 990 filings (2011–2023), Bristol Myers Squibb Foundation Inc's revenue has declined by 84.4%, moving from $35.9M to $5.6M. Total assets decreased by 54.6% over the same period, from $151.7M to $68.8M. Total functional expenses rose by 174%, from $31.8M to $87.1M. In its most recent filing year (2023), Bristol Myers Squibb Foundation Inc reported a deficit of $81.5M, with expenses exceeding revenue. The organization holds $109.1M in liabilities against $68.8M in assets (debt-to-asset ratio: 158.6%), resulting in net assets of $-40,320,456.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2023 $5.6M $87.1M $68.8M $109.1M
2022 $23.4M $45.6M $115.9M $74.8M
2021 $47K $54.4M $146.6M $83.2M View 990
2020 $120.4M $117.5M $185.6M $67.8M View 990
2019 $59.3M $38.3M $116.7M $2.0M View 990
2015 $40.2M $29.6M $96.5M $674K View 990
2014 $37.7M $30.9M $86.0M $722K View 990
2013 $2.8M $34.6M $81.9M $3.5M View 990
2012 $2.7M $34.0M $119.6M $9.5M View 990
2011 $35.9M $31.8M $151.7M $10.2M View 990

Year-by-Year Financial Summary

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Bristol Myers Squibb Foundation Inc:

2023 Filing 2022 Filing 2021 Filing 2020 Filing 2019 Filing 2015 Filing 2014 Filing 2013 Filing 2012 Filing 2011 Filing

Data Sources and Methodology

This transparency report for Bristol Myers Squibb Foundation Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in New Jersey

Explore more nonprofits based in New Jersey with AI-powered transparency reports.

View all New Jersey nonprofits →

Explore Related Nonprofits

Browse by State